• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙黏蛋白/连环蛋白复合物在恶性黑色素瘤中的作用。

The role of cadherin/catenin complex in malignant melanoma.

作者信息

Bonitsis N, Batistatou A, Karantima S, Charalabopoulos K

机构信息

Department of Physiology, Clinical Unit, Ioannina University Medical School, Ioannina, Greece.

出版信息

Exp Oncol. 2006 Sep;28(3):187-93.

PMID:17080010
Abstract

In the present review article the role of cadherin/catenin complex in cases of malignant melanoma is discussed in some detail. Cadherins represent the most important superfamily of adhesion molecules with epithelial E-cadherin being the most studied. Its role in normal state as well as in cancer invasion and metastasis and some other pathologies is crucial. E-cadherin expression is altered in malignant melanomas and its downregulation or absence is associated with melanoma invasion and metastasis potential. A shift from E-cadherin expression to neural N-cadherin expression in melanocytes is also detected in malignant melanomas formation. In addition, a discussion regarding the role of placental P-cadherin and vascular endothelial VE-cadherin as well as the recently identified molecule of dysadherin, is attempted in brief.

摘要

在本综述文章中,将较为详细地讨论钙黏蛋白/连环蛋白复合物在恶性黑色素瘤病例中的作用。钙黏蛋白是最重要的黏附分子超家族,其中上皮E-钙黏蛋白是研究最多的。它在正常状态以及癌症侵袭、转移和其他一些病理过程中的作用至关重要。E-钙黏蛋白的表达在恶性黑色素瘤中会发生改变,其下调或缺失与黑色素瘤的侵袭和转移潜能相关。在恶性黑色素瘤形成过程中还检测到黑色素细胞中从E-钙黏蛋白表达向神经N-钙黏蛋白表达的转变。此外,还简要尝试讨论了胎盘P-钙黏蛋白和血管内皮VE-钙黏蛋白的作用以及最近发现的不黏附素分子的作用。

相似文献

1
The role of cadherin/catenin complex in malignant melanoma.钙黏蛋白/连环蛋白复合物在恶性黑色素瘤中的作用。
Exp Oncol. 2006 Sep;28(3):187-93.
2
E-cadherin/catenin complex in benign and malignant melanocytic lesions.良性和恶性黑素细胞性病变中的E-钙黏蛋白/连环蛋白复合体
J Pathol. 1998 Dec;186(4):350-5. doi: 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K.
3
Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.皮肤恶性黑色素瘤中dysadherin表达的临床病理意义:115例患者的免疫组织化学分析
Cancer. 2005 Apr 15;103(8):1693-700. doi: 10.1002/cncr.20984.
4
Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours.E-钙黏蛋白/连环蛋白(α、β和γ)复合物在癌前和恶性非黑素细胞性皮肤肿瘤中的异常免疫反应性。
J Pathol. 2002 Feb;196(2):154-62. doi: 10.1002/path.1019.
5
E-cadherin and beta-catenin expression patterns in malignant melanoma assessed by image analysis.通过图像分析评估恶性黑色素瘤中E-钙黏蛋白和β-连环蛋白的表达模式。
J Cutan Pathol. 2007 Mar;34(3):239-46. doi: 10.1111/j.1600-0560.2006.00601.x.
6
Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.E-钙黏蛋白胞质结构域对恶性黑色素瘤中内源性N-钙黏蛋白表达的影响
Oncogene. 2006 Jan 12;25(2):248-59. doi: 10.1038/sj.onc.1209054.
7
Expression of motility-related protein MRP1/CD9, N-cadherin, E-cadherin, alpha-catenin and beta-catenin in retinoblastoma.视网膜母细胞瘤中运动相关蛋白MRP1/CD9、N-钙黏蛋白、E-钙黏蛋白、α-连环蛋白和β-连环蛋白的表达
Exp Eye Res. 2007 Apr;84(4):781-9. doi: 10.1016/j.exer.2006.06.014. Epub 2007 Jan 9.
8
P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma.P-钙黏蛋白促进人黑色素瘤中的细胞间黏附并对抗侵袭。
Cancer Res. 2005 Oct 1;65(19):8774-83. doi: 10.1158/0008-5472.CAN-04-4414.
9
The role of E-cadherin/catenin complex in laryngeal cancer.E-钙黏蛋白/连环蛋白复合物在喉癌中的作用。
Exp Oncol. 2005 Dec;27(4):257-61.
10
Restoration of E-cadherin sensitizes human melanoma cells for apoptosis.E-钙黏蛋白的恢复使人类黑色素瘤细胞对凋亡敏感。
Melanoma Res. 2006 Oct;16(5):393-403. doi: 10.1097/01.cmr.0000222595.42685.24.

引用本文的文献

1
Nanotechnology as a Promising Method in the Treatment of Skin Cancer.纳米技术作为治疗皮肤癌的有前途的方法。
Int J Mol Sci. 2024 Feb 10;25(4):2165. doi: 10.3390/ijms25042165.
2
Role of extracellular matrix architecture and signaling in melanoma therapeutic resistance.细胞外基质结构和信号传导在黑色素瘤治疗耐药中的作用
Front Oncol. 2022 Sep 2;12:924553. doi: 10.3389/fonc.2022.924553. eCollection 2022.
3
Constitutive Occurrence of E:N-cadherin Heterodimers in Adherens Junctions of Hepatocytes and Derived Tumors.E:N-钙黏蛋白异二聚体在肝细胞及其衍生肿瘤的黏着连接中的组成性出现。
Cells. 2022 Aug 12;11(16):2507. doi: 10.3390/cells11162507.
4
Influence of Tumor Microenvironment and Fibroblast Population Plasticity on Melanoma Growth, Therapy Resistance and Immunoescape.肿瘤微环境和成纤维细胞群体可塑性对黑色素瘤生长、治疗抗性及免疫逃逸的影响
Int J Mol Sci. 2021 May 17;22(10):5283. doi: 10.3390/ijms22105283.
5
The expressions of YAP1, β-catenin and survivin in colon cancer tissues and their clinical significance.YAP1、β-连环蛋白和生存素在结肠癌组织中的表达及其临床意义。
Int J Clin Exp Pathol. 2018 Dec 1;11(12):6032-6038. eCollection 2018.
6
Network assessment of demethylation treatment in melanoma: Differential transcriptome-methylome and antigen profile signatures.网络评估黑色素瘤去甲基化治疗:差异转录组-甲基组和抗原谱特征。
PLoS One. 2018 Nov 28;13(11):e0206686. doi: 10.1371/journal.pone.0206686. eCollection 2018.
7
VarWalker: personalized mutation network analysis of putative cancer genes from next-generation sequencing data.VarWalker:基于下一代测序数据对假定癌症基因进行个性化突变网络分析
PLoS Comput Biol. 2014 Feb 6;10(2):e1003460. doi: 10.1371/journal.pcbi.1003460. eCollection 2014 Feb.
8
Phenotyping of human melanoma cells reveals a unique composition of receptor targets and a subpopulation co-expressing ErbB4, EPO-R and NGF-R.对人类黑色素瘤细胞进行表型分析发现了受体靶点的独特组成以及共表达ErbB4、促红细胞生成素受体(EPO-R)和神经生长因子受体(NGF-R)的一个亚群。
PLoS One. 2014 Jan 29;9(1):e84417. doi: 10.1371/journal.pone.0084417. eCollection 2014.
9
Stem cells and targeted approaches to melanoma cure.干细胞与黑色素瘤治愈的靶向治疗方法。
Mol Aspects Med. 2014 Oct;39:33-49. doi: 10.1016/j.mam.2013.10.003. Epub 2013 Oct 19.
10
Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.转化生长因子-β与尿激酶型纤溶酶原激活剂:肿瘤发生中的危险组合——对皮肤癌的影响
ISRN Dermatol. 2013 Jul 18;2013:597927. doi: 10.1155/2013/597927. eCollection 2013.